Measure | Participant | Participating supporter | ||||
Eligibility and consent visit | Baseline due <2 months prior to the intervention start date | 8 months due <2 weeks before and <8 weeks after the 8 month anniversary of randomisation | 12 months due <2 weeks before and <8 weeks after the 12 month anniversary of randomisation, if within study timelines | Baseline same timings as participant baseline visit | 8 months same timings as participant 8 month visit | |
Capacity assessment | ✓ | |||||
Mini Mental State Examination | ✓ | |||||
Eligibility checklist | ✓ | ✓ | ||||
Baseline demographics | ✓ | ✓ | ||||
DEMQOL | ✓ | ✓* | ✓ | |||
EQ-5D-5L | ✓ | ✓ | ✓ | ✓ | ✓ | |
PHQ-9 | ✓ | ✓ | ✓ | ✓ | ||
GAD-7 | ✓ | ✓ | ||||
GSE | ✓ | ✓ | ||||
DFS | ✓ | ✓ | ||||
SMAS | ✓ | ✓ | ||||
IADL | ✓ | ✓ | ✓ | |||
HSCRU | ✓ | ✓ | ||||
SCQ | ✓ | ✓ |
*Denotes the primary outcome measure.
DEMQOL, Dementia-Related Quality of Life; DFS, Diener’s Flourishing Scale; EQ-5D-5L, European Quality of Life-5 Dimensions, 5 level version; GAD-7, Generalised Anxiety Disorder-7; GSE, General Self-Efficacy Scale; HSCRU, Health and Social Care Resource Use Questionnaire; IADL, Instrumental Activities of Daily Living; PHQ-9, Patient Health Questionnaire-9; SCQ, Sense of Competency Questionnaire; SMAS, Self-Management Ability Scale.